WO2003068316A1 - Formulations cosmetiques contenant des polymeres antimicrobiens - Google Patents

Formulations cosmetiques contenant des polymeres antimicrobiens Download PDF

Info

Publication number
WO2003068316A1
WO2003068316A1 PCT/EP2002/013705 EP0213705W WO03068316A1 WO 2003068316 A1 WO2003068316 A1 WO 2003068316A1 EP 0213705 W EP0213705 W EP 0213705W WO 03068316 A1 WO03068316 A1 WO 03068316A1
Authority
WO
WIPO (PCT)
Prior art keywords
methacrylate
acrylate
antimicrobial
vinyl
cosmetic formulations
Prior art date
Application number
PCT/EP2002/013705
Other languages
German (de)
English (en)
Inventor
Peter Ottersbach
Martina Inhester
Original Assignee
Creavis Gesellschaft Für Technologie Und Innovation Mbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Creavis Gesellschaft Für Technologie Und Innovation Mbh filed Critical Creavis Gesellschaft Für Technologie Und Innovation Mbh
Priority to AU2002358598A priority Critical patent/AU2002358598A1/en
Publication of WO2003068316A1 publication Critical patent/WO2003068316A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8158—Homopolymers or copolymers of amides or imides, e.g. (meth) acrylamide; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/001—Preparations for care of the lips
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q9/00—Preparations for removing hair or for aiding hair removal
    • A61Q9/02—Shaving preparations

Definitions

  • the invention relates to cosmetic applications and formulations which contain antimicrobial polymers.
  • Mucus layers often form, which cause microbial populations to rise extremely, which have a lasting impact on the quality of water, beverages and food, and which can even spoil the goods and damage the health of consumers.
  • Bacteria must be kept away from all areas of life where hygiene is important. This affects textiles for direct body contact, especially for the genital area and for nursing and elderly care. In addition, bacteria must be kept away from furniture and device surfaces in care stations, in particular in the area of intensive care and the care of small children, in hospitals, in particular in rooms for medical interventions and in isolation stations for critical infections and in toilets.
  • the formulation of cosmetics e.g. B. ointments, creams, soaps or deodorants, bacterial colonization before or after application is a common problem.
  • the bacterial contamination leads to a reduced usability, shelf life or an unpleasant smell.
  • the antimicrobial agents are e.g. B. in deodorants, which are applied directly to the skin to cause decomposition of sweat components and to minimize the associated odor, part of the cosmetic effect.
  • deodorants which are applied directly to the skin to cause decomposition of sweat components and to minimize the associated odor, part of the cosmetic effect.
  • skin creams which often have to be preserved before they are actually used.
  • the anti-microbial components of these systems come into direct contact with the skin of the user, but are more for preserving the cream than used as an active component of the cream.
  • antimicrobial-based cosmetics can be produced on the basis of antimicrobial polymers, which cosmetics meet the described requirements in an almost ideal manner.
  • the present invention therefore relates to antimicrobial cosmetic formulations containing 0.001-30% by weight of at least one antimicrobial polymer.
  • Cosmetic formulation in the sense of the present invention is understood to mean all formulations which are usually referred to as cosmetics, such as, for example, B. deodorant sprays, deodorant rollers, skin creams, soaps, toothpastes, hairspray or shaving foam.
  • antimicrobial polymers such as z. B. EP 0 862 858, DE 100 24 270, DE 100 22 406, PCT / EP00 / 06501, DE 100 14 726, DE 100 08 177, PCT / EP00 / 06812, PCT / EP00 / 06487, PCT / EP00 / 06506 , PCT / EP00 / 02813, PCT / EP00 / 02819, PCT / EP00 / 02818, PCT / EP00 / 02780, PCT / EP00 / 02781, PCT / EP00 / 02783, PCT / EP00 / 02782, PCT / EP00 / 02799, PCT / EP00 / 02798, PCT / EP00 / 00545 or PCT / EP00 / 00544, are known.
  • These polymers do not contain any low molecular weight components; the antimicrobial properties are due to the contact of bacteria with their surface.
  • All common cosmetics especially deodorants, creams, lotions, shaving foams and gels, hair sprays, hair fixatives, hair dyes, face masks, conditioners, toothpastes, mouthwashes, or also decorative cosmetics, such as. B. make-ups, can be made microbicidal by adding the antimicrobial polymers in the course of the manufacturing process of the cosmetics or afterwards.
  • the antimicrobial cosmetic formulations produced in this way can be used like conventional cosmetics. So is spraying on surfaces to be disinfected, in particular
  • antimicrobial cosmetics which combine both the application properties required for the tasks and the biochemical inhibitory effect on microbial growth in an almost ideal manner. Since the antimicrobial polymer does not release any low-molecular constituents into the environment and thus into ambient air, the systems according to the invention have a relatively long-lasting effect in contrast to conventional active substances.
  • Nitrogen and phosphorus functionalized monomers are preferably used to prepare the antimicrobial polymers.
  • these polymers are prepared from at least one of the following monomers: 2-tert-butylaminoethyl methacrylic acid, 2-diethylaminoethyl methacrylic acid,
  • Preferred polymers for these applications are:
  • further aliphatic unsaturated monomers can be used in the production of the antimicrobial polymers, the proportion of these unsaturated monomers without nitrogen or phosphorus functionality being at most 50 mole percent in the resulting copolymer.
  • These are in particular acrylates or methacrylates, acrylic acid, tert-butyl methacrylate or methyl methacrylate, styrene or its derivatives, vinyl chloride, vinyl ether, vinyl pyrrolidone, acrylamides, acrylonitriles, olefins, ethylene, propylene, butylene, isobutylene, allyl compounds, vinyl ketones, vinyl acetic acid, Vinyl acetate or vinyl ester, methacrylic acid methyl ester, methacrylic acid ethyl ester, methacrylic acid butyl ester, methacrylic acid tert-butyl ester, acrylic acid methyl ester, acrylic acid ethyl ester, acrylic acid butyl ester and
  • the cosmetic formulations according to the invention can contain all of the ingredients conventionally used in cosmetics. These are listed in the Cosmetic Ingredient Review (CIR) of the CTFA (Cosmetics, Toiletry, Fragrance Association), to which express reference is made here.
  • CIR Cosmetic Ingredient Review
  • CTFA Cosmetic Ingredient Review
  • Preferred further ingredients of the formulations according to the invention are water, aluminum chlorohydrate, PPG-15 searyl ether, steareth-2, steareth-21, trisodium EDTA, glyceryl laurate, Persea Gratissima, octyldodecanol, bisalcohol, triethanolamine, plasmitic acid, stearic acid, isopentane, propylene glycolitolostearate Isobutane, hydroxymethyl cellulose, propylene glycol, PEG 150 distearate, paraffinum liquidum, glyceryl stearate, stearic acid, allantoin, methyl paraben, propyl paraben, sorbitol, pentasodium triphosphate, sodium lauryl sulfate, sodium fluoride, phenyl ether, dimethyl ether Benzophenone and / or isopropyl myristate.
  • ingredients are added in the usual amounts in the cosmetics sector.
  • An octylacrylamide / acrylate / butylaminoethyl methacrylate terpolymer is excluded from use in a formulation according to the invention.
  • the proportion of the antimicrobial polymers in the cosmetic formulations can be 0.001 to 30% by weight, preferably 0.01 to 20% by weight, particularly preferably 0.01 to 10% by weight.
  • the addition of an antimicrobial aqueous emulsion prepared on the basis of an antimicrobial polymer also offers itself.
  • the antimicrobial polymer is then present in the formulations according to the invention in solid, dissolved or dispersed form.
  • Another object of the present invention is the use of the antimicrobial cosmetic formulations according to the invention.
  • the formulations can be used in particular as a skin cream, sunscreen, shaving gel, shaving foam, soap, shampoo, deodorant, lip care agent, make-up, toothpaste, lotion, mouthwash, conditioner, hairspray, hair fixative, hair dye, face mask or perfume.
  • the mixture from example la is spread on a cotton pad, which is then dried at 30 ° C. for 6 hours.
  • the coated cotton wool pad from example 1b is placed on the bottom of a beaker containing 10 ml of a test microbial suspension of Pseudomonas aeruginosa.
  • the system prepared in this way is now shaken for a period of 4 hours. Then 1 mL of the test microbial suspension is removed. After this time, the number of germs has dropped from 10 to 10 germs per mL.
  • Example ld The coated cotton wool pad from example lb is placed on the bottom of a beaker containing 10 ml of a test germ suspension of Staphylococcus aureus. The system prepared in this way is now shaken for a period of 4 hours. Then 1 mL of the test microbial suspension is removed. After this time, no Staphylococcus aureus germs can be detected.
  • Example le A coated cotton wool pad from example lb is blended with Chlorella sp., Trentepohlia sp., Gloeocapsa sp., Calothrix sp. and Aspergilus niger. These samples are then placed in an incubator for 3 weeks. In contrast to running control samples, no growth can be detected on any of the treated cotton pads.
  • Example la 20 mL of the product from Example la are placed in a commercially available spray bottle. A cotton wool pad is then sprayed using this spray bottle, which is then dried at 30 ° C. for 6 hours.
  • the coated cotton wool pad from example lf is placed on the bottom of a beaker containing 10 ml of a test microbial suspension of Pseudomonas aeruginosa.
  • the system prepared in this way is now shaken for a period of 4 hours. Then 1 mL of the test microbial suspension is removed. After this time, the number of germs dropped from 10 7 to 10 2 germs per mL.
  • the coated cotton wool pad from example lf is placed on the bottom of a beaker containing 10 ml of a test germ suspension of Staphylococcus aureus.
  • the system prepared in this way is now shaken for a period of 4 hours. Then 1 mL of the test microbial suspension is removed. After this time, no Staphylococcus aureus germs can be detected.
  • One coated cotton pad from example lf is blended with Chlorella sp., Trentepohlia sp., Gloeocapsa sp., Calothrix sp. and Aspergilus niger. These samples are then placed in an incubator for 3 weeks. In contrast to running control samples, no growth can be detected on any of the treated cotton pads.
  • Example lj 2 mL of the product from Example 1 are placed in 20 mL of a commercial shaving gel from Gilette (Gilette Gel Normal), which consists of water, triethanolamine, palmitic acid, stearic acid, isopentane, propylene glycol isostearate, sorbitol, isobutane, hydroxymethyl cellulose, propylene glycol and PEG-150 distearate consists.
  • Gilette Gibette (Gilette Gel Normal)
  • the mixture is then homogenized by vigorous stirring.
  • Example lj The mixture from Example lj is spread onto a cotton pad, which is then dried at 30 ° C. for 4 hours.
  • the coated Cotton Upad from Example lk is placed on the bottom of a beaker containing 10 L of a test microbial suspension of Pseudomonas aeruginosa.
  • the system prepared in this way is now shaken for a period of 4 hours. Then 1 mL of the test microbial suspension is removed. After this time, the number of germs is from 10 to 10
  • the coated cotton wool pad from example lk is placed on the bottom of a beaker containing 10 ml of a test germ suspension of Staphylococcus aureus.
  • the system prepared in this way is now shaken for a period of 4 hours. Then 1 mL of the test microbial suspension is removed. After this time, no Staphylococcus aureus germs can be detected.
  • One coated cotton pad from example lk is coated with Chlorella sp., Trentepohlia sp., Gloeocapsa sp., Calothrix sp. and Aspergilus niger. These samples are then placed in an incubator for 3 weeks. In contrast to running control samples, no growth can be detected on any of the treated cotton pads.
  • Example lo 2 mL of the product from Example 1 are in 30 mL of a commercially available hand cream from E. Kiessling & Cie. GmbH & Co. (Ombia SAN), which consists of water, paraffinum liquidum, glyceryl stearate, cera alba, stearic acid, allantoin, methyl paraben and propyl paraben. The mixture is then homogenized by vigorous stirring.
  • a commercially available hand cream from E. Kiessling & Cie. GmbH & Co.
  • Example 10 The mixture from Example 10 is spread onto a cotton pad, which is then dried at 30 ° C. for 4 hours.
  • the coated cotton wool pad from example lp is placed on the bottom of a beaker containing 10 ml of a test microbial suspension of Pseudomonas aeruginosa.
  • the system prepared in this way is now shaken for a period of 4 hours. Then 1 mL of the test microbial suspension is removed. At the end of this time, the number of bacteria increased from 10 7 to 10 5
  • the coated cotton wool pad from example lp is placed on the bottom of a beaker containing 10 ml of a test germ suspension of Staphylococcus aureus.
  • the system prepared in this way is now shaken for a period of 4 hours. Then 1 mL of the test microbial suspension is removed. After this time, no Staphylococcus aureus germs can be detected.
  • One coated cotton pad from example lp is coated with Chlorella sp., Trentepohlia sp., Gloeocapsa sp., Calothrix sp. and Aspergilus niger. These samples are then placed in an incubator for 3 weeks. In contrast to running control samples, no growth can be detected on any of the treated cotton pads.
  • Example lt The mixture from Example lt is spread onto a cotton pad, which is then dried at 30 ° C. for 4 hours.
  • the coated cotton wool pad from example lu is placed on the bottom of a beaker containing 10 ml of a test microbial suspension of Pseudomonas aeruginosa.
  • the system prepared in this way is now shaken for a period of 4 hours. Then 1 mL of the test microbial suspension is removed. At the end of this time, the number of bacteria increased from 10 7 to 10 5
  • the coated cotton wool pad from example lu is placed on the bottom of a beaker containing 10 ml of a test germ suspension of Staphylococcus aureus.
  • the system prepared in this way is now shaken for a period of 4 hours. Then 1 mL of the test microbial suspension is removed. After this time, no Staphylococcus aureus germs can be detected.
  • One coated cotton pad from example lu is coated with Chlorella sp., Trentepohlia sp., Gloeocapsa sp., Calothrix sp. and Aspergilus niger. These samples are then placed in an incubator for 3 weeks. In contrast to running control samples, no growth can be detected on any of the treated cotton pads.
  • Example 2 10 mL dimethylaminopropyl methacrylamide (Aldrich), 24 g of a 70% aqueous solution of Triton X 405 (Aldrich), 100 mL deionized water and 0.3 g potassium peroxodisulfate (Aldrich) are placed in a three-necked flask and placed under Argon inflow heated to 60 ° C. A further 90 mL of dimethylaminopropylmefhacrylamide are then added dropwise over a period of 4 hours. The mixture is then stirred at 60 ° C. for a further 2 hours, after which the resulting emulsion is allowed to cool to room temperature.
  • Example 2a 2 mL of the product from Example 2 are added to 50 mL of a commercial deodorant formulation from Beiersdorf (Nivea Balsam Roll-on Sensitive), which consists of water, aluminum chlorohydrate, PPG-15 stearyl ether, steareth-2, steareth-21, Trisodium EDTA, Glyceryl Laurat, Persea Gratissima, Octyldodecanol and Bisabolol. The mixture is then homogenized by shaking vigorously.
  • Beiersdorf Nea Balsam Roll-on Sensitive
  • Example 2a The mixture from Example 2a is spread onto a cotton pad, which is then dried at 30 ° C. for 6 hours.
  • the coated cotton wool pad from example 2b is placed on the bottom of a beaker containing 10 ml of a test germ suspension of Pseudomonas aeruginosa.
  • the system prepared in this way is now shaken for a period of 4 hours. Then 1 mL of the test microbial suspension is removed. After this time the number of germs decreased from 10 7 to 10 4 germs per mL.
  • Example 2e The coated cotton wool pad from Example 2b is placed on the bottom of a beaker containing 10 mL of a test germ suspension of Staphylococcus aureus. The system prepared in this way is now shaken for a period of 4 hours. Then 1 L of the test germ suspension is removed. After this time, no Staphylococcus aureus germs can be detected.
  • Example 2e The coated cotton wool pad from Example 2b is placed on the bottom of a beaker containing 10 mL of a test germ suspension of Staphylococcus aureus. The system prepared in this way is now shaken for a period of 4 hours. Then 1 L of the test germ suspension is removed. After this time, no Staphylococcus aureus germs can be detected.
  • Example 2e Example 2e:
  • Example 2b One coated cotton pad from Example 2b is blended with Chlorella sp., Trentepohlia sp., Gloeocapsa sp., Calothrix sp. and Aspergilus niger. These samples are then placed in an incubator for 3 weeks. In contrast to running control samples, no growth can be detected on any of the treated cotton pads.
  • Example 3a 20 mL of the product from Example 3a are placed in a commercially available spray bottle. A cotton wool pad is then sprayed using this spray bottle, which is then dried at 30 ° C. for 6 hours.
  • Example 3 c The coated cotton wool pad from example 3b is placed on the bottom of a beaker containing 10 ml of a test microbial suspension of Pseudomonas aeruginosa. The system prepared in this way is now shaken for a period of 4 hours. Then 1 mL of the test microbial suspension is removed. After this time, the number of germs has dropped from 10 to 10 germs per mL.
  • Example 3b The coated cotton wool pad from Example 3b is placed on the bottom of a beaker containing 10 mL of a test germ suspension of Staphylococcus aureus.
  • the system prepared in this way is now shaken for a period of 4 hours. Then 1 mL of the test microbial suspension is removed. After this time, no Staphylococcus aureus germs can be detected.
  • Example 3e A coated cotton pad from Example 3b is blended with Chlorella sp., Trentepohlia sp., Gloeocapsa sp., Calothrix sp. and Aspergilus niger. These samples are then placed in an incubator for 3 weeks. In contrast to running control samples, no growth can be detected on any of the treated cotton pads.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biomedical Technology (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne des formulations cosmétiques, et leurs utilisations, qui contiennent des polymères antimicrobiens.
PCT/EP2002/013705 2002-02-12 2002-12-04 Formulations cosmetiques contenant des polymeres antimicrobiens WO2003068316A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002358598A AU2002358598A1 (en) 2002-02-12 2002-12-04 Cosmetic formulations that contain antimicrobial polymers

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10205924.1 2002-02-12
DE10205924A DE10205924A1 (de) 2002-02-12 2002-02-12 Kosmetische Formulierungen mit antimikrobiellen Polymeren

Publications (1)

Publication Number Publication Date
WO2003068316A1 true WO2003068316A1 (fr) 2003-08-21

Family

ID=27618634

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/013705 WO2003068316A1 (fr) 2002-02-12 2002-12-04 Formulations cosmetiques contenant des polymeres antimicrobiens

Country Status (3)

Country Link
AU (1) AU2002358598A1 (fr)
DE (1) DE10205924A1 (fr)
WO (1) WO2003068316A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004035012A1 (fr) * 2002-10-18 2004-04-29 Ciba Specialty Chemicals Holding Inc. Utilisation de peptides biomimetiques dans des compositions de soins personnels
DE102008033343A1 (de) * 2008-07-14 2010-01-21 Beiersdorf Ag Kosmetische Zubereitung mit neutralisierter 2-Phenylbenzimidazol-5-sulfonsäure
DE102009040089A1 (de) * 2009-09-04 2011-07-21 Beiersdorf AG, 20253 Zubereitungen mit wasserunlöslichen polymeren Aminen zur Verminderung von Körpergeruch

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004012363A1 (de) * 2004-03-11 2005-09-29 Beiersdorf Ag Anti-Adhäsivum
FR2976485B1 (fr) * 2011-06-20 2013-10-11 Oreal Utilisation comme agent anti-transpirant d'un polymere hydrodispersible floculant comportant des groupements amines non quaternises

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990006125A1 (fr) * 1988-12-05 1990-06-14 Olin Corporation Utilisation de polymeres contenant du pyrithione comme agents antimicrobiens dans les produits cosmetiques
JPH05310544A (ja) * 1992-05-14 1993-11-22 Chisso Corp 抗う蝕および抗歯周病剤
EP0591024A2 (fr) * 1992-09-23 1994-04-06 Centre Technique Industriel dit: INSTITUT TEXTILE DE FRANCE Polymère antiseptique
WO2002069709A1 (fr) * 2001-03-08 2002-09-12 Creavis Gesellschaft Für Technologie Und Innovation Mbh Systemes de fluides microbicides contenant des polymeres antimicrobiens

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990006125A1 (fr) * 1988-12-05 1990-06-14 Olin Corporation Utilisation de polymeres contenant du pyrithione comme agents antimicrobiens dans les produits cosmetiques
JPH05310544A (ja) * 1992-05-14 1993-11-22 Chisso Corp 抗う蝕および抗歯周病剤
EP0591024A2 (fr) * 1992-09-23 1994-04-06 Centre Technique Industriel dit: INSTITUT TEXTILE DE FRANCE Polymère antiseptique
WO2002069709A1 (fr) * 2001-03-08 2002-09-12 Creavis Gesellschaft Für Technologie Und Innovation Mbh Systemes de fluides microbicides contenant des polymeres antimicrobiens

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PATENT ABSTRACTS OF JAPAN vol. 018, no. 118 (C - 1172) 25 February 1994 (1994-02-25) *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004035012A1 (fr) * 2002-10-18 2004-04-29 Ciba Specialty Chemicals Holding Inc. Utilisation de peptides biomimetiques dans des compositions de soins personnels
DE102008033343A1 (de) * 2008-07-14 2010-01-21 Beiersdorf Ag Kosmetische Zubereitung mit neutralisierter 2-Phenylbenzimidazol-5-sulfonsäure
DE102009040089A1 (de) * 2009-09-04 2011-07-21 Beiersdorf AG, 20253 Zubereitungen mit wasserunlöslichen polymeren Aminen zur Verminderung von Körpergeruch

Also Published As

Publication number Publication date
AU2002358598A1 (en) 2003-09-04
DE10205924A1 (de) 2003-08-21

Similar Documents

Publication Publication Date Title
US7192601B2 (en) Antimicrobial and sporicidal composition
EP1725210B1 (fr) Utilisation d'un extrait eau/ethanol d'hibiscus pour traiter les odeurs corporelles
CA2487270C (fr) Compositions antimicrobiennes ainsi que produits et procedes mettant en oeuvre celles-ci
DE60020342T2 (de) Tiefeindringende antimikrobielle zusammensetzungen
EP0754028B1 (fr) Nouvelles compositions desodorisantes et antimicrobiennes destinees a etre utilisees dans des preparations cosmetiques ou topiques
US7569530B1 (en) Antimicrobial compositions, products and methods employing same
EP2841050A1 (fr) Formulation contenant de l'éthanolamide caprylique et/ou de l'éthanolamide caprique associé à un sel d'aluminium, et son utilisation
EA013501B1 (ru) Композиции для личной и домашней гигиены на основе дигидроцитрата серебра
GB1569423A (en) Potentiated antimicrobial compositions
CN104010525A (zh) 环己醇衍生物作为抗菌抗微生物活性物质的用途
NO177886B (no) Munnskyllevann som virker mot plaque
US8741271B2 (en) Antimicrobial compositions containing essential oils
EP2213165A1 (fr) Nouvelles compositions contenant un agent tensio-actif ozonisé
WO2010031657A2 (fr) Utilisation de dérivés d'urée et de sels de phenacyl thiazolium pour le traitement d'odeurs corporelles
DE102007045242A1 (de) Benzaldehyde in kosmetischen oder dermatologischen Zubereitungen
EP3532012B1 (fr) Compositions de soins capillaires comprenant des matières qui modifient le sébum
WO2016012420A2 (fr) Préparations de déodorants contenant des polymères polyquaternium-6
DE69916695T2 (de) Verwendung mindestens eines Hydroxystilben als Mittel zur Verringerung der Adhäsion von Mikroorganismen
EP1651037A1 (fr) Alcools secondaires utilises en tant que principes actifs antimicrobiens
JP4193443B2 (ja) 殺菌剤および防腐剤
DE10025124A1 (de) Kombinationen von Glycerinmo9noalkylethern und Aryl-substituierten Alkoholen
WO2003068316A1 (fr) Formulations cosmetiques contenant des polymeres antimicrobiens
WO2011032924A1 (fr) 2-hydroxyéthylamides antimicrobiens
JP3658626B2 (ja) 化粧品および医薬部外品
DE102013215435A1 (de) Formulierung enthaltend Caprylsäureethanolamid und/oder Caprinsäureethanolamid in Kombination mit einem Tensid

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP